Purple (PRPL) Q2 Earnings: What To Expect

Purple (NASDAQ: PRPL) is set to report Q2 earnings Monday after market close. The prior quarter missed revenue expectations, with revenue of $95.73M, down 8.1% YoY. For Q2, analysts expect revenue to fall 2.5% YoY. The article cites peer results from Mohawk Industries and Leggett & Platt and notes PRPL’s $25 average price target vs. $9.54 shares.

Original reporting
Published Aug 9, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 3:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Purple (PRPL) Q2 Earnings: What To Expect — source image
Decision brief

The 30-second read

$PRPLNeutralMed
01

Why it matters

The main tradable event is the upcoming earnings release, with consensus expecting revenue to decline 2.5% YoY versus a 12.6% decline a year ago.

02

Market read

This is a pre-earnings preview anchored to prior misses and consensus expectations, with peer results offered as directional context.

03

What to watch

The article does not mention Purple’s gross margin, inventory, promotional intensity, or any new guidance details that typically drive earnings reactions.

Relevance 4/10Novelty 4/10Timing: ahead of Monday after-market-close Q2 earnings

Background

Purple missed revenue and EPS expectations last quarter and also missed full-year revenue guidance versus analysts.

Company-level read

Ticker impact

$PRPLNeutralMedium confidence
Context

Purple is set to report Q2 earnings Monday after the close, with prior-quarter revenue and EPS misses shaping expectations.

Expected impact

Likely volatility around revenue/EPS versus expectations, with direction dependent on whether the quarter improves from the prior-year decline.

Evidence & confidence

The text frames expectations (revenue -2.5% YoY) and notes reconfirmed estimates, but does not disclose any fresh company-specific development beyond the scheduled earnings date.

Market effects

Home furnishings retailers’ recent prints (Mohawk, Leggett & Platt) are used as read-through, potentially influencing positioning into Purple’s report.

None stated.

None stated.

Counterpoint

If peers’ results were stronger than expected, Purple could surprise on margins or demand, despite the article’s cautious framing from last quarter.

Key entities

  • Purple

    Bedding and comfort retailer scheduled to report Q2 earnings Monday after market close.

  • Mohawk Industries

    Peer cited as having delivered YoY revenue growth and a post-results stock move.

  • Leggett & Platt

    Peer cited as having reported a revenue decline but beat estimates, with a negative post-results move.

Related articles

$ROADMed

Construction Partners, Inc. Q3 2026 Earnings Call Summary

Construction Partners, Inc. reported Q3 2026 results driven by cost pass-through amid energy inflation and unusually wet weather. Management said Sunbelt demand tied to AI data centers and acquisitions support growth. Fiscal 2026 guidance was raised to over 30% revenue and margin growth, with 75% to 85% EBITDA to operating cash flow and leverage targeting 2.5x.

$RXOMed

RXO Q2 Earnings Call Highlights

RXO (NYSE:RXO) reported Q2 spot freight rising to 42% of truckload volume, up 900 bps sequentially and 1,500 bps YoY. Truckload gross profit per load rose 11% sequentially, while brokerage margin fell 70 bps to 10.7% on higher fuel. Complementary services revenue rose 7% to $488M. Q3 adjusted EBITDA guidance is $35M to $45M; adjusted free cash flow was -$42M in Q2.

$ZDMed

Ziff Davis Q2 Earnings Call Highlights

Ziff Davis (NASDAQ:ZD) reported Q2 call highlights. Advertising and performance-marketing revenue fell 6% YoY and subscription and licensing revenue was flat. Other revenue rose over 2x, up about $3.7M, mainly from Semantic Labs. Cash was $1.6B and long-term investments $100M. The company accelerated buybacks, repurchasing 2.6M shares for $121.5M, and expects Q3 revenue to rise sequentially but fall YoY.

$RYNMed

Rayonier Q2 Earnings Call Highlights

Rayonier (NYSE: RYN) reported Q2 segment updates on its earnings call. Southern Timber adjusted EBITDA rose to $53M, Northwest Timber to $26M, and Wood Products adjusted EBITDA was $25M. Real estate revenue was $54M. The company repurchased 3.5M shares for $72M, ended with $412M cash, and guided full-year harvest volumes and Real Estate adjusted EBITDA of $180M-$200M.

$ZLABMed

Zai Lab Q2 Earnings Call Highlights

Zai Lab (NASDAQ:ZLAB) said it plans to seek China NRDL inclusion for VYVGART HYTRULO and shift the VYVGART franchise from IV to subcutaneous. Management flagged timing effects on second-half revenue, aims to stabilize revenue before stronger 2027 growth, and reported $717.5M cash. It outlined zoci ADC Phase III plans and pipeline updates.

$SAROMedAI 8/10

StandardAero Q2 Earnings Call Highlights

StandardAero (NYSE:SARO) reported Q2 Engine Services revenue up 4% to $1.405B and adjusted EBITDA up 14.4% to $204M, with margin rising 130 bps to 14.5%. Component Repair Services revenue rose 9.2% to $195M, but adjusted EBITDA fell 0.9% to $51M. Military/helicopter revenue declined 3% due to input delays, but full-year growth outlook was maintained. 2026 guidance raised: revenue $6.375B-$6.5B, adj EBITDA $885M-$910M, adj EPS $1.50-$1.57.